Herman Scholtz

Director at Infinity Bio

Capital raised by Infinity Bio

$2.0M+$2.0M latest round

1 Form D filing · first filed Feb 2025 · Baltimore, MD

CURRENT ROLE: Director
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: 2023
30D INTEREST: 2 ↗

Career

1 company on file · founded 2023

Infinity BioBiotech · Baltimore, MDsince 2023

Director

Listed on Infinity Bio's Form D filings

Company filings

via EDGAR · Form D for Infinity Bio1

DateCompanyFormAmountRole on filing

Feb 18, 2025Infinity BioForm D+$2.0M—

Form DFeb 18, 2025 · Infinity Bio+$2.0Mnot a signer

Overview

Last filing Feb 18, 2025

Herman Scholtz is on file as Director at Infinity Bio in Baltimore, MD. Infinity Bio has 1 Form D filing on record, $2.0M raised in total.

Teammates

Infinity Bio · 1

Joy M. NassifChief Executive OfficerSigner

Products

Infinity Bio · 1

MIPSA (Molecular Indexing of Proteins by Self-Assembly)Antibody Profiling Technology

MIPSA is Infinity Bio's proprietary technology designed for the intricate mapping of antibody reactivity against large libraries of antigens. This innovative platform allows for comprehensive profiling of antibodies, facilitating a deeper understanding of immune responses.